Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS) - Full Text View

Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)

This study has been completed.

Sponsored by:	National Eye Institute (NEI)
Information provided by:	National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:	NCT00001612

Purpose

Patients enrolled in the original Early Treatment Diabetic Retinopathy Study at the Clinical Center at Johns Hopkins Wilmer Eye Institute will be invited for a follow-up visit at the National Eye Institute. Visual function will be assessed with manifest refraction and standardized visual acuity measurement. The progression of retinopathy will be evaluated by ocular exam and fundus photography. A brief medical history will be obtained. The goal of this study is to evaluate the long-term results of patients whose diabetic retinopathy was treated with different strategies of scatter and/or focal laser photocoagulation.

Condition

Diabetic Retinopathy

MedlinePlus related topics:

Diabetic Eye Problems Retinal Disorders

U.S. FDA Resources

Study Type:	Observational

Official Title:	Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:	170
Study Start Date:	May 1997
Estimated Study Completion Date:	August 2000

Detailed Description:

To evaluate the long-term clinical course and prognosis of diabetic retinopathy treated with different strategies of scatter and/or focal laser photocoagulation in patients enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS).

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Patient was originally enrolled in the Early Treatment Diabetic Retinopathy Study at the Johns Hopkins Wilmer Eye Institute.

Patient not previously enrolled are not eligible.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001612

Locations


United States, Maryland
	National Eye Institute (NEI)
	Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Eye Institute (NEI)

More Information

Publications:

Ferris FL 3rd. How effective are treatments for diabetic retinopathy? JAMA. 1993 Mar 10;269(10):1290-1. No abstract available.

Study ID Numbers:	970120, 97-EI-0120
First Received:	November 3, 1999
Last Updated:	March 3, 2008
ClinicalTrials.gov Identifier:	NCT00001612
Health Authority:	United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):

Diabetic Retinopathy

Long-Term Visual Outcome

Photocoagulation

J. H. Wilmer Eye Institute

Study placed in the following topic categories:

Diabetic Retinopathy

Eye Diseases

Diabetes Mellitus

Vascular Diseases

Endocrine System Diseases

Endocrinopathy

Diabetes Complications

Retinal Diseases

Diabetic Angiopathies

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on November 30, 2008